Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need.
• PRT2527 demonstrated activity across a range of relapsed/refractory lymphoid malignancies, including patients who received prior CAR-T therapy • Prelude plans to seek a partner for future...
WILMINGTON, Del., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will...
Presented interim data from the ongoing Phase 1 dose escalation study of PRT3789, its first-in-class IV SMARCA2 degrader, demonstrating clinical proof of concept Initiated a Phase 1 trial for...
– Interim data from ongoing trial of PRT3789 showed additional clinical activity at higher doses in patients with non-small cell lung cancer (NSCLC) – First safety data presented from combination...
WILMINGTON, Del., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, today announced...
- Encouraging signs of anti-tumor activity including objective responses observed in patients with SMARCA4-mutated non-small cell lung cancer (NSCLC) and esophageal cancer in early PRT3789...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.01535 | -1.60648874935 | 0.9555 | 1.1298 | 0.91 | 534488 | 0.96574961 | CS |
| 4 | -0.12985 | -12.1355140187 | 1.07 | 1.1298 | 0.91 | 380667 | 0.98196985 | CS |
| 12 | -1.61985 | -63.275390625 | 2.56 | 2.72 | 0.91 | 343494 | 1.4176896 | CS |
| 26 | -3.24985 | -77.562052506 | 4.19 | 6.8 | 0.91 | 282916 | 2.70776754 | CS |
| 52 | -2.37985 | -71.6822289157 | 3.32 | 6.8 | 0.91 | 176757 | 2.95051848 | CS |
| 156 | -13.02985 | -93.2702219041 | 13.97 | 15.57 | 0.91 | 169149 | 5.3785124 | CS |
| 260 | -24.81985 | -96.3503493789 | 25.76 | 95.375 | 0.91 | 198687 | 17.56538248 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
